Waltham, United States
Metenova, a Repligen Company is a technology leader in the global pharmaceutical and biotech industry, specializing in magnetic mixing technologies. The company's patented products offer magnetic contactless power transfer for mixing pharmaceuticals, catering to the needs of both present and future requirements. With a strong customer-focused approach, Metenova provides high levels of service and application support. The company was founded in 2009 and is headquartered in the United States.
The latest private equity round investment took place on 01 January 2018, with Priveq as the investor. This investment reflects the confidence of the investor in the company's innovative technology and strong position in the market.
Metenova's alignment with Repligen Corporation further strengthens its position in the bioprocessing space. The company continues to drive technological development to ensure its customers achieve even greater success in the industry. To learn more about Metenova and Repligen Corporation's solutions, visit www.repligen.com.
